AstraZeneca
strong underlying performance in and double digit total revenue and core growth and prior year double digit growth across focus therapy areas prior year total revenue core upgraded guidance total revenue and core expected to increase by high teens percentage | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
November 2024
Slide
5 of 38
Related slides by other companies
Deliveroo
Results
March 2024
summary a year of good progress | Deliveroo
Avantor
Results
October 2023
revenue | Avantor
Samsara
Investor Presentation
December 2022
financial guidance non | Samsara
Verint
SPAC
July 2019
actionable intelligence global leader strong momentum accelerating revenue growth double digit growth core i growth significant | Verint
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Investor Event
September 2024
Results
February 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io